#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Leber's congenital amaurosis Alagille syndrome Congenital megacolon Retinal artery occlusion Non-small cell lung cancer metastatic Hypersensitivity pneumonitis Paraganglion neoplasm Haemophilia B without inhibitors Gaucher's disease type I Synovial sarcoma recurrent Liposarcoma Krabbe's disease Primary adrenal insufficiency Philadelphia positive chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Diagnostics Methylmalonic acidaemia – Life with Disease Angelman’s syndrome – Basic Information Cerebral arteriovenous malformation haemorrhagic Hepatic angiosarcoma – Trials in Disease Prader-Willi syndrome – Treatment Glycogen storage disease type V – Treatment Hereditary motor and sensory neuropathy – Basic Information Gaucher’s disease type I – Trials in Disease Haemolytic uraemic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Fibrinogen Levocabastine Hydrochloride Zasocitinib Asparaginase Cevostamab Imiquimod Lysine Acetate NERANDOMILAST Telisotuzumab Vedotin Certolizumab Pegol Gadobenate Dimeglumine Caspofungin Dulaglutide Odm-111 Doxazosin Doxazosin Mesilate Oritavancin Hu5F9‐G4 OMEGA-3-ACID ETHYL ESTERS 90 Ficlatuzumab More therapies…

    Learn about Your Condition

    Septic shock Thyroid cancer metastatic Diffuse large B-cell lymphoma Dyspepsia Head injury Plasma cell myeloma recurrent Meniscus injury Myxofibrosarcoma Migraine with aura Progressive multiple sclerosis Arteriovenous graft thrombosis Osteogenesis imperfecta Spinal muscular atrophy Systemic sclerosis pulmonary Univentricular heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of ORIC-114 Alone or with Chemotherapy for Patients with Advanced Solid Tumors with EGFR or HER2 Alterations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Oric-114
    Poland Spain

  • Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Elritercept
    Czechia France Germany Spain

  • Study on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    Denmark Germany Italy The Netherlands Spain

  • Study on Apomorphine Hydrochloride and Sodium Chloride for Patients with Severe Brain Injury and Disorders of Consciousness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Sodium Chloride
    Belgium Spain

  • Study on Pomalidomide for HIV Control in Patients on ART and During Treatment Interruption

    Recruiting

    1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Pomalidomide
    Denmark Spain

  • Study on Ibuprofen vs. Conventional Treatment for Patients with Acute Myocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Ibuprofen
    Spain
Previous Page
1 … 369 370 371 372 373 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!